Outlook Therapeutics (OTLK) EPS (Basic): 2015-2024
Historic EPS (Basic) for Outlook Therapeutics (OTLK) over the last 10 years, with Sep 2024 value amounting to -$4.06.
- Outlook Therapeutics' EPS (Basic) rose 108.33% to $0.02 in Q3 2020 from the same period last year, while for Sep 2020 it was -$0.99, marking a year-over-year increase of 59.09%. This contributed to the annual value of -$4.06 for FY2024, which is 13.98% up from last year.
- As of FY2024, Outlook Therapeutics' EPS (Basic) stood at -$4.06, which was up 13.98% from -$4.72 recorded in FY2023.
- In the past 5 years, Outlook Therapeutics' EPS (Basic) ranged from a high of -$0.31 in FY2022 and a low of -$4.72 during FY2023.
- Its 3-year average for EPS (Basic) is -$3.03, with a median of -$4.06 in 2024.
- Per our database at Business Quant, Outlook Therapeutics' EPS (Basic) spiked by 66.16% in 2020 and then crashed by 1,422.58% in 2023.
- Outlook Therapeutics' EPS (Basic) (Yearly) stood at -$0.67 in 2020, then soared by 47.76% to -$0.35 in 2021, then grew by 11.43% to -$0.31 in 2022, then crashed by 1,422.58% to -$4.72 in 2023, then climbed by 13.98% to -$4.06 in 2024.